Status:
COMPLETED
An Investigation Into Bone Micro-architecture in Women With Type 2 Diabetes
Lead Sponsor:
Hamilton Health Sciences Corporation
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
McMaster University
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
FEMALE
65+ years
Brief Summary
The number of people with type 2 diabetes is growing. This puts a lot of pressure on the health care systems. Type 2 diabetes is often associated with health problems, like poor eyesight, muscle coord...
Eligibility Criteria
Inclusion
- female
- \>= 65 years old
- postmenopausal for \> 5 years (WHO definition of menopause)
Exclusion
- currently taking osteoporosis related medication (HRT, SERM, bisphosphonate, PTH, calcitonin, fluoride)
- had cancer in past 10 years, likely to metastasize to bone (ie: breast, lung)
- have intrinsic bone disease (ie: Paget's Disease, Cushings syndrome)
- have untreated malabsorption syndrome (ie: Celiac Disease)
- renal insufficiency (CrCl \<30ml/min)
- hyperparathyroidism, hypoparathyroidism
- chronic systemic glucocorticosteroid use \> 3mos, dose\>2.5mg daily
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00982371
Start Date
September 1 2008
End Date
December 1 2011
Last Update
June 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McMaster University
Hamilton, Ontario, Canada, L8N 3Z5